By InvitationNot Applicable

Qualitative Effects of AEF0217 in Down Syndrome People

Spain28 participantsStarted 2026-03-01

Plain-language summary

Following the AEF0217-102 trial (NCT05748405), which investigated the effects of AEF0217 versus placebo, participants with Down syndrome and their caregivers who took part in the trial are invited to share their perceptions of what they experienced or observed, in an exploratory manner. This qualitative study collects information through a specific questionnaire developed for this purpose.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participants having completed the trial AEF0217-102
✓. Being the caregiver of the participant
✓. Provided written informed consent (or assent in case of individuals with Down syndrome with no capacity to legally sign the consent)

What they're measuring

- Overall, how would the caregiver describe the experience with the effect of the treatment the participant received during the trial?

Timeframe: Day 1

Trial details

NCT IDNCT07413224

SponsorAelis Farma

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-05

View on ClinicalTrials.gov More Down Syndrome (Trisomy 21) trials